A Randomized Controlled Trial of Diabetes Screening Immediately Postpartum (DIP)
Pre-Gestational Diabetes, Type2diabetes, Pregnancy in Diabetic
About this trial
This is an interventional prevention trial for Pre-Gestational Diabetes focused on measuring 2-hour oral glucose tolerance test (OGTT), Pregnancy, diabetes mellitus screening
Eligibility Criteria
Inclusion Criteria: Immediately postpartum individuals during their delivery hospital admission ≥ 18 years old with the ability to give informed consent. Diagnosed with gestational diabetes (GDM) during pregnancy by a one-hour 50-gram glucose challenge test ≥200 mg/dL at greater than 20 weeks of gestation or two elevated values on a 3-hour 100-gram glucose tolerance test at greater than 20 weeks of gestation (Carpenter/Coustan criteria). English or Spanish speaking Receiving prenatal and postpartum care at OSU Exclusion Criteria: Individuals who cannot tolerate a 2-hour oral glucose tolerance test (OGTT) (i.e. history of gastric bypass) Not English or Spanish speaking
Sites / Locations
- The Ohio State University Wexner Medical Center OB/GYN Maternal and Fetal MedicineRecruiting
Arms of the Study
Arm 1
Arm 2
Active Comparator
Other
Immediate inpatient postpartum OGTT
Standard of care
The intervention includes immediate inpatient postpartum 2-hour oral glucose tolerance test (OGTT) prior to delivery discharge
Standard of care is 4-12 week outpatient postpartum OGTT